Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Liposome Drug Delivery Market Players Focus on Boosting Research Activities, Market Likely to Gain ~US$ 8 Bn in Revenues during 2019-2027: TMR

This image opens in the lightbox

News provided by

Transparency Market Research

14 Dec, 2020, 14:30 GMT

Share this article

Share toX

Share this article

Share toX

-  Global liposome drug delivery market is foreseen to grow at attractive CAGR of ~9% during tenure of 2019 to 2027. Increased number of cancer patients and rising research activities are likely to fuel market growth in years ahead.

-  North America liposome drug delivery market is likely to continue its dominance during assessment period.

ALBANY, N.Y., Dec. 14, 2020 /PRNewswire/ -- Liposome refers to a spherical vesicle that has minimum one lipid bilayer. In healthcare sector, liposomes are utilized as a vehicle for pharmaceutical drugs and nutrients administration. Increased research and development activities in the healthcare sector worldwide are estimated to generate prominent expansion avenues in the global liposome drug delivery market in the forthcoming years.

Liposomes are gathering traction across healthcare sector owing to their ability to work as potential antiviral agents that will assist in decreasing economic burden and social impact occurred owing to the COVID-19 pandemic. Enterprises working in the liposome drug delivery market are focused on the development of liposomes that provide high solubility and extended circulating time to advance drug release profiles.

Request for Analysis of COVID-19 Impact on Liposome Drug Delivery Market – https://www.transparencymarketresearch.com/covid19.php

Key Findings of Liposome Drug Delivery Market Report

  • The liposome drug delivery market is likely to grow at CAGR of ~9% in the forecast period 2019–2027.
  • Thus, the market is predicted to gather revenues of ~US$ 8 Bn by 2027 end.
  • The market was accounted for approximately US$ 3.6 Bn in 2018.
  • Of all applications, the cancer therapy was dominant segment in the liposome drug delivery market during 2018.
  • The aforementioned segment is slated to continue this growth trend in the forthcoming years.
  • North America was dominant region in the market in 2018.
  • Abovementioned region is estimated to maintain its dominant position during assessment period.
  • The nature of liposome drug delivery market is moderately fragmented with presence of many well-entrenched enterprises.

Explore 199 pages of top-notch research, incisive insights, and detailed country-level projections on Liposome Drug Delivery Market (Product: Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others; Technology: Stealth Liposome Technology, Non-PEGylated Liposome Technology, and DepoFoam Liposome Technology; and Application: Fungal Diseases, Pain Management, Cancer Therapy, Viral Vaccines, and Photodynamic Therapy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 at https://www.transparencymarketresearch.com/report-toc/28571

 Liposome Drug Delivery Market: Key Driving Factors and Promising Avenues

  • Liposome drug delivery is gaining popularity owing to many advantages it offers. One of the key advantages is the ability of this system to capture both lipophilic and hydrophilic compounds together with allowing a wide range of medications to be encapsulated by these vesicles. This scenario depicts that the global liposome drug delivery market will grow at rapid pace in the forthcoming years.
  • The global liposome drug delivery market is estimated to grow at striking pace throughout the forecast period of 2019 to 2027. One of the key reasons attributed to this growth is rising cases of cancer. Liposome encapsulated drugs are widely utilized in the treatment of this deadly disease.
  • The market for liposome drug delivery is predicted to gather higher revenues on the back of rising use of liposomes as drug delivery system owing to its numerous advantages. Moving forward, the market will expand at swift pace due to technological advancements and sturdy pipeline of medications in the forthcoming years.

Purchase the Liposome Drug Delivery Market Report - https://www.transparencymarketresearch.com/checkout.php

Liposome Drug Delivery Market: Competitive Assessment

  • Major enterprises in the global liposome drug delivery market are focused on discovery of novel lipid compositions. Apart from this, companies are eyeing optimization of the stability as well as drug vehiculization abilities of liposomes. All these activities are indicative of the promising growth curve of the global liposome drug delivery market in the forthcoming period.
  • The list of important companies working in the liposome drug delivery market includes Astellas Pharma, Inc., Spectrum Pharmaceuticals, Inc., Celsion Corporation, Gilead Sciences, Inc., Pacira BioSciences, Inc., Ipsen Pharma, Novartis AG, Luye Pharma Group, Johnson & Johnson, and Takeda Pharmaceutical Company Limited.

Browse More Press Release - https://www.transparencymarketresearch.com/press-releases.htm

The liposome drug delivery market can be segmented as follows:

Product

  • Liposomal Doxorubicin
  • Liposomal Paclitaxel
  • Liposomal Amphotericin B
  • Others

Technology

  • Stealth Liposome Technology
  • Non-PEGylated Liposome Technology
  • DepoFoam Liposome Technology

Application

  • Fungal Diseases
  • Cancer Therapy
  • Pain Management
  • Viral Vaccines
  • Photodynamic Therapy

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:

Pulmonary Drug Delivery Devices Market: According to the report, the global pulmonary drug delivery devices market was valued at US$ 36,159.9 Mn in 2018 and is projected to expand at a CAGR of 2.7% from 2019 to 2027, increase in the prevalence and incidence of respiratory diseases across globe, increasing population of smokers across countries, rising prescription of the combination therapies, and rising research & development in the asthma & COPD treatment' are projected to drive the market

COPD Drug Delivery Devices Market: Some of the innovations that are likely to take place within the COPD drug delivery devices market are expected to focus on digital technologies linked with inhalers, chemistry and formulations, and design and device engineering. Moreover, research and development activities are being undertaken to improve targeted drug delivery to the lungs.

Drug and Gene Delivery Systems Market: The global drug and gene delivery systems market was valued at approximately US$ 512 Bn in 2016 and is anticipated to register a CAGR of above 6% from 2017 to 2025, to reach value of approximately US$ 917 Bn by 2025. The reagents & consumables segment is likely to fuel the global drug and gene delivery systems market from 2017 to 2025.

Browse Our Latest Reports - https://www.transparencymarketresearch.com/latest.htm

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

Browse More Upcoming Reports by Transparency Market Research: https://www.transparencymarketresearch.com/upcoming.htm

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Press Release Source:
 https://www.transparencymarketresearch.com/pressrelease/liposome-drug-delivery-market.htm
Website
: https://www.transparencymarketresearch.com/

LOGO: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.